OrthoPediatrics Partner iotaMotion Receives FDA Clearance for Expanded Pediatric Use
OrthoPediatrics announced its partner, iotaMotion, has received FDA 510(k) clearance for expanded pediatric use of its iotaSOFT Insertion System. The system is now cleared for use in patients four years of age and older, extending access to robotic-assisted cochlear implantation for school-aged children. "This milestone allows us to leverage our existing capabilities and bring the same discipline, focus, and pediatric-first expertise beyond orthopedics. We are excited to extend our ability to help more children through improved clinical care and efficiency in the ENT space with an advanced technology like iotaSOFT," commented David Bailey, President & CEO of OrthoPediatrics.
